Literature DB >> 11679554

In vitro antimicrobial susceptibility of Aerococcus urinae to 14 antibiotics, and time-kill curves for penicillin, gentamicin and vancomycin.

R Skov1, J J Christensen, B Korner, N Frimodt-Møller, F Espersen.   

Abstract

Aerococcus urinae is a newcomer in clinical and microbiological practice, causing urinary tract infections, bacteraemia/septicaemia and/or endocarditis. This study presents for the first time an evaluation of the activity of a representative panel of antibiotics against a large number of A. urinae isolates. The in vitro susceptibilities (MICs) of 56 isolates of A. urinae to 14 antibiotics were determined by agar dilution. In general, A. urinae isolates showed little inter-isolate variability, and had low MICs of penicillin, amoxicillin, piperacillin, cefepime, vancomycin and rifampicin. High-level aminoglycoside resistance was not found for any of the isolates. Moderate to good activity was seen with quinolones, erythromycin and tetracycline. Isolates from two patients with endocarditis were studied with time-kill curves for penicillin, gentamicin and vancomycin. Penicillin and vancomycin alone exhibited slow or no bactericidal activity against the two strains. When combining either penicillin or vancomycin with gentamicin, rapid bactericidal activity was obtained for both strains with both combinations. The treatment options for A. urinae seem to include penicillins for less severe cases. In severe cases, i.e. endocarditis, the time-kill investigations suggest a beneficial effect of combination with gentamicin. In the penicillin-allergic patient vancomycin in combination with gentamicin represents the most obvious alternative.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11679554     DOI: 10.1093/jac/48.5.653

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  22 in total

1.  First molecular characterization of fluoroquinolone resistance in Aerococcus spp.

Authors:  Vincent Cattoir; Alfred Kobal; Patrick Legrand
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

2.  Aerococcus Viridans: A Rare Pathogen Causing Urinary Tract Infection.

Authors:  Balvinder Mohan; Kamran Zaman; Naveen Anand; Neelam Taneja
Journal:  J Clin Diagn Res       Date:  2017-01-01

3.  Aerococcus urinae and trimethoprim-sulfamethoxazole.

Authors:  Romney M Humphries; Courtney Lee; Janet A Hindler
Journal:  J Clin Microbiol       Date:  2011-09-14       Impact factor: 5.948

4.  In vitro antimicrobial susceptibility of Aerococcus urinae.

Authors:  Romney M Humphries; Janet A Hindler
Journal:  J Clin Microbiol       Date:  2014-03-26       Impact factor: 5.948

5.  Clinical and microbiological features of infective endocarditis caused by aerococci.

Authors:  Torgny Sunnerhagen; Bo Nilson; Lars Olaison; Magnus Rasmussen
Journal:  Infection       Date:  2015-06-29       Impact factor: 3.553

6.  Platelet activation and biofilm formation by Aerococcus urinae, an endocarditis-causing pathogen.

Authors:  Oonagh Shannon; Matthias Mörgelin; Magnus Rasmussen
Journal:  Infect Immun       Date:  2010-08-09       Impact factor: 3.441

7.  Aerococcus urinae: severe and fatal bloodstream infections and endocarditis.

Authors:  Margriet F C de Jong; Robin Soetekouw; Reinier W ten Kate; Dick Veenendaal
Journal:  J Clin Microbiol       Date:  2010-07-21       Impact factor: 5.948

8.  Aerococcus urinae Isolated from Women with Lower Urinary Tract Symptoms: In Vitro Aggregation and Genome Analysis.

Authors:  Evann E Hilt; Catherine Putonti; Krystal Thomas-White; Amanda L Lewis; Karen L Visick; Nicole M Gilbert; Alan J Wolfe
Journal:  J Bacteriol       Date:  2020-06-09       Impact factor: 3.490

Review 9.  Spondylodiscitis due to Aerococcus urinae and literature review.

Authors:  Estelle Rougier; Antoine Braud; Xavier Argemi; Nicolas Lefebvre; Daniel Christmann; Yves Hansmann; Nawal Douiri
Journal:  Infection       Date:  2018-02-16       Impact factor: 3.553

10.  A population-based study of aerococcal bacteraemia in the MALDI-TOF MS-era.

Authors:  E Senneby; L Göransson; S Weiber; M Rasmussen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-02       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.